Abstract:MicroRNAs play an indispensable role in numerous biological processes ranging from organismic development to tumor <a class="link-external link-http" href="http://progression.In" rel="external noopener nofollow">this http URL</a> oncology,these microRNAs constitute a fundamental regulation role in the pathology of cancer that provides the basis for probing into the influences on clinical features through transcriptome data. Previous work focused on machine learning (ML) for searching biomarkers in different cancer databases, but the functions of these biomarkers are fully not clear. Taking lung cancer as a prototype case of study. Through integrating clinical information into the transcripts expression data, we systematically analyzed the effect of microRNA on diagnostic and prognostic factors at deteriorative lung adenocarcinoma (LUAD). After dimension reduction, unsupervised hierarchical clustering was used to find the diagnostic factors which represent the unique expression patterns of microRNA at various patient's stages. In addition, we developed a classification framework, Light Gradient Boosting Machine (LightGBM) and SHAPley Additive explanation (SHAP) algorithm, to screen out the prognostic factors. Enrichment analyses show that the diagnostic and prognostic factors are not only enriched in cancer-related athways, but also involved in many vital cellular signaling transduction and immune responses. These key microRNAs also impact the survival risk of LUAD patients at all (or a specific) stage(s) and some of them target some important Transcription Factors (TF).The key finding is that five microRNAs (hsa-mir-196b, hsa-mir-31, hsa-mir-891a, hsa-mir-34c, and hsa-mir-653) can then serve as not only potential diagnostic factors but also prognostic tools in the monitoring of lung cancer.

Progress of miR-196 in the development and diagnosis of non-small cell lung cancer

The Modulating Mechanisms of miRNA-196 in Malignancies and Its Prognostic Value: A Systematic Review and Meta-Analysis

Function of microRNA-145 and mechanisms underlying its role in malignant tumor diagnosis and treatment.

MicroRNAs: A novel potential biomarker for diagnosis and therapy in patients with non-small cell lung cancer

Research Progress on Lung Cancer Related MicroRNAs

The role of microRNA-196a in tumorigenesis, tumor progression, and prognosis

Roles of Microrna in Diagnosis, Therapy and Prognosis of Lung Cancer

Advances of Microrna in Lung Cancer

Mir-30D-5p: A Non-Coding RNA with Potential Diagnostic, Prognostic and Therapeutic Applications

miRNA-based biomarkers, therapies, and resistance in Cancer

The Clinical Value of Mir‐193a‐3p in Non‐small Cell Lung Cancer and Its Potential Molecular Mechanism Explored in Silico Using RNA‐sequencing and Microarray Data

Correction: Non-small-cell Lung Cancer and Mirnas: Novel Biomarkers and Promising Tools for Treatment

Regulatory Mechanism of Mir-20A-5p Expression in Cancer

Roles and mechanisms of miR-195-5p in human solid cancers

The expression of miR-197 and miR-203 in serum of non-small cell lung cancer

Progress of the Studies on Relationship Between MicroRNAs and Lung Cancer

Mirna Expression and Its Clinical Implications for the Prevention and Diagnosis of Non-Small-cell Lung Cancer

Systematic analysis reveals key microRNAs as diagnostic and prognostic factors in progressive stages of lung cancer

Expression profile analysis of microRNAs and downregulated miR-486-5p and miR-30a-5p in non-small cell lung cancer

Micrornas Associated With Therapy Of Non-Small Cell Lung Cancer

Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.